SEC Form 4 · accession 0001415889-17-001860
INNOVUS PHARMACEUTICALS, INC. · INNV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randy Berholtz
Officer — EVP, CORPORATE DEVELOPMENT
Period of report
Nov 22, 2017
Accepted (ET)
Nov 27, 2017 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 22, 2017 | P | 4,990 | $0.0968 | A | 4,990 | D | |
| Common Stock | Nov 22, 2017 | P | 4,900 | $0.0967 | A | 9,890 | D | |
| Common Stock | Nov 22, 2017 | P | 4,990 | $0.0968 | A | 14,880 | D | |
| Common Stock | Nov 22, 2017 | P | 2,000 | $0.0954 | A | 16,880 | D |
Table II — derivative securities
No Table II lines on this filing.